Innata Bio is pioneering a new class of anti‑inflammatory medicines built on a simple but powerful idea: inflammation shouldn’t be turned off — it should be precisely controlled.
Where today’s therapies act like binary switches, shutting down entire pathways, Innata’s small molecule modulators fine‑tune the IL‑6/gp130 axis to reduce harmful inflammation while preserving the regenerative and homeostatic signals the body uses to deploy the immune system to heal.
This is inflammation redefined — precision over suppression, tuning over blocking, biology restored rather than silenced.